Cancer information and support
Patient resource: Immunotherapy for the treatment of hematologic cancers
The promise of CAR-T cell therapy
Innovative Medicine Initiative (IMI) is a EU public-private partnership funding health research and innovation. Complex therapies like CAR-T cells pose questions no drug developer can answer on their own.
CAR T-cell therapy: Reprogramming the immune system to treat cancer | Rob Weinko...
At the Malaghan Institute for Biomedical Reserach,researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.